Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

13523-86-9

Pindolol

13523-86-9
452105-33-8

5-(5-Fluoro2oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-diethyl-1H-pyrrole3carboxylic acid

452105-33-8
92-84-2

Phenothiazine

92-84-2
1405-20-5

Polymyxin B Sulfate

1405-20-5
81262-93-3

Procaterol HCl 1/2H2O

81262-93-3
53-60-1

Promazine HCl

53-60-1
447399-55-5

Pyroxasulfone

447399-55-5
389574-19-0

Prasugrel HCl

389574-19-0
345-78-8

Pseudoephedrine HCl

345-78-8
87-08-1

Phenoxymethylpenicillin

87-08-1
101-26-8

Pyridostigmine Bromide

101-26-8
630-67-1

Predocol

630-67-1
55837-27-9

Piretanide

55837-27-9
849061-97-8

Quercetin H2O

849061-97-8
111974-72-2

Quetiapine Hemifumarate

111974-72-2
77-95-2

D-(-)-Quinic Acid

77-95-2
130-89-2

Quinine HCl

130-89-2
207671-44-1

Quinine hemisulfate salt monohydrate

207671-44-1
6119-47-7

Quinine HCl 2H2O

6119-47-7
580-16-5

6-Quinolinol

580-16-5